Operating Lease, Liability in USD of NGM BIOPHARMACEUTICALS INC from Q4 2021 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: NGM BIOPHARMACEUTICALS INC quarterly Operating Lease, Liability history and change rate from Q4 2021 to Q3 2023.
NGM BIOPHARMACEUTICALS INC Operating Lease, Liability for the quarter ending 30 Sep 2023 was $1.38M.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

NGM BIOPHARMACEUTICALS INC Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$1.38M			30 Sep 2023	10-Q	02 Nov 2023
Q2 2023	$2.75M			30 Jun 2023	10-Q	03 Aug 2023
Q1 2023	$4.07M			31 Mar 2023	10-Q	04 May 2023
Q4 2022	$5.39M	-$1.3M	-19.5%	31 Dec 2022	10-K	28 Feb 2023
Q4 2021	$6.69M			31 Dec 2021	10-Q	03 Nov 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.